---
title: "ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/528ebfe3-d498-5bea-b63a-d29b2aa865ae
json: https://whiteintel.dev/api/public/dossier/528ebfe3-d498-5bea-b63a-d29b2aa865ae
identifier: oo:GB-COH-10138701
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-10138701`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/528ebfe3-d498-5bea-b63a-d29b2aa865ae  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/528ebfe3-d498-5bea-b63a-d29b2aa865ae  

## Ownership & control

### Owners / controllers

- **ENVISION PHARMA BIDCO LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/c1a76a14-92d3-5250-8992-7c23bca2cadc
- **ENVISION PHARMA BIDCO LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/c1a76a14-92d3-5250-8992-7c23bca2cadc

### Holdings / subsidiaries

- **ENVISION PHARMA HOLDCO LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/53d3e1ca-6b6b-5fac-a1ac-83eac48fe52b
- **TOUCH CREATIVE DESIGN LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/63c1b96d-9f14-54d2-8758-59961f0f64a0
- **TOUCH CREATIVE DESIGN LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/63c1b96d-9f14-54d2-8758-59961f0f64a0
- **ENVISION PHARMA HOLDCO LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/53d3e1ca-6b6b-5fac-a1ac-83eac48fe52b

### UBO chain (walk to the ultimate owner)

A **14-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `10138701`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2016-04-21
- **Registered office:** Envision House, 5 North Street, Horsham, West Sussex, RH12 1XQ
- **SIC:** 74909

### Officers

- DEUTSCH, Adam Brent, Mr. — director · American · appointed 2024-08-20
- RUDNICK, Stanford Benjamin — director · American · appointed 2024-12-09
- GILLIE, John David — director · British · appointed 2016-07-06 · resigned 2021-08-10
- HEIM, Margaret — director · American · appointed 2023-02-21 · resigned 2023-08-02
- HOLLIS KORTH, Joshua — director · American · appointed 2021-12-14 · resigned 2024-11-15
- LADRIERE, Bruno Serge Leon — director · French · appointed 2016-04-21 · resigned 2020-11-04
- LYALL-COTTLE, Simon William — director · British · appointed 2016-04-21 · resigned 2018-11-26
- MILLER III, Howard Collins — director · American · appointed 2023-09-12 · resigned 2024-12-31
- MORTIMER, Michael Irvine — director · American · appointed 2020-11-04 · resigned 2021-12-14
- PONTI, Andrea — director · Italian,American · appointed 2020-11-04 · resigned 2021-12-14
- SETTON, Daniel Jacques Joseph Alexandre — director · French · appointed 2016-04-21 · resigned 2020-11-04
- WITCHER, Benjamin Maurice Frederick — director · British · appointed 2018-11-26 · resigned 2020-11-04

### Beneficial owners (Persons with Significant Control)

- [Envision Pharma Bidco Limited](https://whiteintel.dev/entity/c1a76a14-92d3-5250-8992-7c23bca2cadc) — 75–100% shares · corporate PSC · England — since 2016-04-21

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/10138701
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/10138701

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED**. Human view: https://whiteintel.dev/entity/528ebfe3-d498-5bea-b63a-d29b2aa865ae · Structured JSON: https://whiteintel.dev/api/public/dossier/528ebfe3-d498-5bea-b63a-d29b2aa865ae._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._